Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-720-9 | CAS number: 1219826-66-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
Description of key information
The structurally similar N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine, given via the diet daily for 104 weeks, has no carcinogenic potential in rats.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Link to relevant study records
- Endpoint:
- carcinogenicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Justification for type of information:
- For details and justification of read-across please refer to the report attached in section 0.2 of IUCLID.
- Dose descriptor:
- NOAEL
- Effect level:
- 4 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- other: Effect type: toxicity (migrated information)
- Dose descriptor:
- LOAEL
- Effect level:
- 8 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
- Remarks on result:
- other: Effect type: toxicity (migrated information)
- Conclusions:
- N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine, given via the diet daily for 104 weeks, has no carcinogenic potential in rats.
- Executive summary:
The test item N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine was tested for carcinogenic potential in male and female rats. The animals were treated with 4 or 8 mg N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine/kg b.w./day by dietary administration for 104 weeks or with 20/15/12 mg N-(3-aminopropyl)-N-dodecylpropane- 1,3-diamine/kg b.w./day by dietary administration for 61 weeks (high dosed male animals) or 81 weeks (high dosed female animals).
A dose-related systemic toxicity was noted. A MTD (maximum tolerated dose) as defined by the ICH guideline S1C(R2): 'Dose Selection for Carcinogenicity Studies of Pharmaceuticals' in form of e.g. no more than 10% decrease in body weight gain relative to controls, target organ toxicity and/or significant alterations in clinical pathological parameters was met by the 8 mg/kg dose level:
The body weight of the males and females treated with 8 mg N-(3-aminopropyl)-Ndodecylpropane-1,3-diamine/kg b.w./day was below the body weight of the control group from approximately test week 53 onwards in males (by up to 14%, statistically significant at p ≤ 0.01 in test weeks 59 to 91, 95 and 101) and from test week 75 onwards in females (by up to 12%, statistically not significant at p ≤ 0.01). In addition, changes were noted for biochemical and haematological parameters and non-neoplastic changes were noted in the heart, kidneys, skeletal muscle of the leg and larynx and mesenteric lymph nodes.
Hence, the 8 mg/kg dose was considered to be the maximum tolerated dose suitable for histopathological evaluation for neoplastic changes.
All neoplastic lesions recorded in this study were commonly encountered in rats of this strain and age. Type, incidence, and severity of the lesions recorded were not increased in the test-item treated animals as compared to the control animals.
It is concluded, that N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine, given via the diet daily for 104 weeks, has no carcinogenic potential in rats.
This information is used in a read-across approach in the assessment of the target substance. For details and justification of read-across please refer to the read-across report attached to IUCLID section 0.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Data for branched triamine C16-18 is based on read across from astructurally similar branched triamine C12 which was tested for carcinogenic potential in a carcinogenicity study according to OECD 453 and showed no carcinogenic potential in rats when given via the diet daily for 104 weeks.
Additional information
Data is based on read across from astructurally similar branched triamine C12. Branched triamine C16-18 only differs in the length of the alkyl chain, which issuspected to influence bioavailability, but not chemical reactivity and route of metabolisation, aspects that influence specific mechanisms of toxicity. For these reasons, many of the studies can best be performed on the substance with the shortest chain length within a group of structurally similar substances, as this is considered to result to the lowest NOAEL or most likely able to show specific effects.
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine was tested for carcinogenic potential in male and female rats. The animals were treated with 4 or 8 mg/kg b.w./day by dietary administration for 104 weeks or with 20/15/12 mg/kg b.w./day by dietary administration for 61 weeks (high dosed male animals) or 81 weeks (high dosed female animals).
A dose-related systemic toxicity was noted. A MTD was met by the 8 mg/kg dose level:
The body weight of the males and females treated with 8 mg/kg b.w./day was below the body weight of the control group from approximately test week 53 onwards in males (by up to 14%) and from test week 75 onwards in females (by up to 12%). In addition, changes were noted for biochemical and haematological parameters and non-neoplastic changes were noted in the heart, kidneys, skeletal muscle of the leg and larynx and mesenteric lymph nodes.
Hence, the 8 mg/kg dose was considered to be the maximum tolerated dose suitable for histopathological evaluation for neoplastic changes.
All neoplastic lesions recorded in this study were commonly encountered in rats of this strain and age. Type, incidence, and severity of the lesions recorded were not increased in the test-item treated animals as compared to the control animals.
It is concluded, that N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine, given via the diet daily for 104 weeks, has no carcinogenic potential in rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.